GXE:ETR
Lakefront Biotherapeutics NV
€ 26.46
arrow_downward
-0.15%(-0.040) 1D
10-р сарын 13, 13:17:34 (GMT+2) · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GXE...
Open
€ 26.40
High
€ 26.46
Low
€ 26.40
Mkt. cap
1.74 тэрбум
Avg. vol.
523.00
Volume
0.00
P/E ratio
2.92
52-wk high
€ 30.02
52-wk low
€ 22.84
EPS
€ 9.05
No. of employees
196
Open
€ 26.40
High
€ 26.46
Low
€ 26.40
Mkt. cap
1.74 тэрбум
Avg. vol.
523.00
Volume
0.00
P/E ratio
2.92
52-wk high
€ 30.02
52-wk low
€ 22.84
EPS
€ 9.05
No. of employees
196
News stories
From web sources and news partners
Morningstar
·
59 минутын өмнө
XCF Global (Nasdaq:SAFX) Announces $12M+ in Gross Product Sales and Shipments of 1.4 Million Gallons of Renewable Diesel in September
Stock Titan
·
29 минутын өмнө
Nasdaq closed Immutep's listing case after 10 business days meeting the $1 bid minimum.
TradingView
·
24 минутын өмнө
Humana AB (HUM) To Be Delisted From Nasdaq Stockholm
24/7 Wall St.
·
1 цагийн өмнө
Buffett Says a Know-Nothing Investor Can Beat the Pros. $250 a Month in the S&P 500 Could Turn Into $508,000
Profile
Lakefront Biotherapeutics is a Belgian pharmaceutical research company which was founded in 1999. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb.
The company develops drugs against rheumatoid arthritis, Crohn's disease, ulcerative colitis, psoriasis, systemic lupus erythematosus and cystic fibrosis. Wikipedia
About Lakefront Biotherapeutics NV